CD274 and non-small cell lung carcinoma: Evidence from mostly retrospective analyses of clinical trials in the first- (1L) or second-line treatment of NSCLC suggests that TMB predicts the efficacy of PD-L1/PD-1 inhibitor monotherapy, but not in combination with chemotherapy3, and that tTMB is positively correlated with bTMB17.